Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Uncovering disease mechanisms through network biology in the era of next generation sequencing.

  • Piñero González, Janet, 1977-
  • Berenstein, Ariel José
  • González-Pérez, Abel
  • Chernomoretz, Ariel
  • Furlong, Laura I., 1971-
Characterizing the behavior of disease genes in the context of biological networks has the potential to shed light on disease mechanisms, and to reveal both new candidate disease genes and therapeutic targets. Previous studies addressing the network properties of disease genes have produced contradictory results. Here we have explored the causes of these discrepancies and assessed the relationship between the network roles of disease genes and their tolerance to deleterious germline variants in human populations leveraging on: the abundance of interactome resources, a comprehensive catalog of disease genes and exome variation data. We found that the most salient network features of disease genes are driven by cancer genes and that genes related to different types of diseases play network roles whose centrality is inversely correlated to their tolerance to likely deleterious germline mutations. This proved to be a multiscale signature, including global, mesoscopic and local network centrality features. Cancer driver genes, the most sensitive to deleterious variants, occupy the most central positions, followed by dominant disease genes and then by recessive disease genes, which are tolerant to variants and isolated within their network modules., We received support from UBACyT (20020130100582BA) and MinCyT (PICT2014-2701), ISCIII-FEDER (PI13/00082, CP10/00524), IMI-JU under grants agreements n° 115002 (eTOX), n° 115191 (Open PHACTS)], n° 115372 (EMIF) and n° 115735 (iPiE), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution, and the EU H2020 Programme 2014-2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB). A.G.-P. is supported by a Ramon y Cajal scholarship funded by the Spanish Ministry of Economy. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

psygenet2r: a R/Bioconductor package for the analysis of psychiatric disease genes

  • Gutiérrez Sacristán, Alba
  • Hernández Ferrer, Carles
  • González, Juan Ramón
  • Furlong, Laura I., 1971-
MOTIVATION: Psychiatric disorders have a great impact on morbidity and mortality. Genotype-phenotype resources for psychiatric diseases are key to enable the translation of research findings to a better care of patients. PsyGeNET is a knowledge resource on psychiatric diseases and their genes, developed by text mining and curated by domain experts. RESULTS: We present psygenet2r, an R package that contains a variety of functions for leveraging PsyGeNET database and facilitating its analysis and interpretation. The package offers different types of queries to the database along with variety of analysis and visualization tools, including the study of the anatomical structures in which the genes are expressed and gaining insight of gene's molecular function. Psygenet2r is especially suited for network medicine analysis of psychiatric disorders. AVAILABILITY AND IMPLEMENTATION: The package is implemented in R and is available under MIT license from Bioconductor (http://bioconductor.org/packages/release/bioc/html/psygenet2r.html)., This work was supported by ISCIII-FEDER [PI13/00082, CP10/00524, CPII16/00026], MICINN [MTM2015-68140-R], IMI-JU under grants agreements no. 115191 (Open PHACTS), no. 115372 (EMIF), no. 115735 (iPiE), resources of which are composed of financial contribution from the EU-FP7 [FP7/2007–2013] and EFPIA companies in kind contribution, and the EU H2020 Programme 2014–2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a member of ELIXIR-ES and the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023, of the PE I + D+i 2013-2016, funded by ISCIII and FEDER. A.G.S. acknowledges financial support from the Spanish Ministry of Economy and Competitiveness, through the ‘María de Maeztu’ Programme for Units of Excellence in R&D [MDM-2014-0370].
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

DisGeNET-RDF: harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases.

  • Queralt Rosinach, Núria
  • Piñero González, Janet, 1977-
  • Bravo Serrano, Àlex, 1984-
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
MOTIVATION: DisGeNET-RDF makes available knowledge on the genetic basis of human diseases in the Semantic Web. Gene-disease associations (GDAs) and their provenance metadata are published as human-readable and machine-processable web resources. The information on GDAs included in DisGeNET-RDF is interlinked to other biomedical databases to support the development of bioinformatics approaches for translational research through evidence-based exploitation of a rich and fully interconnected linked open data., We received support from ISCIII-FEDER (PI13/00082, CP10/00524), from the IMI-JU under grants agreements no. 115002 (eTOX), no. 115191 (Open PHACTS), no. 115372 (EMIF) and no. 115735 (iPiE), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in kind contribution, and the EU H2020 Programme 2014–2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Development of an infrastructure for the prediction of biological endpoints in industrial environments. Lessons learned at the eTOX Project

  • Pastor Maeso, Manuel
  • Quintana, Jordi
  • Sanz, Ferran
In silico methods are increasingly being used for assessing the chemical safety of substances, as a part of integrated approaches involving in vitro and in vivo experiments. A paradigmatic example of these strategies is the eTOX project http://www.etoxproject.eu, funded by the European Innovative Medicines Initiative (IMI), which aimed at producing high quality predictions of in vivo toxicity of drug candidates and resulted in generating about 200 models for diverse endpoints of toxicological interest. In an industry-oriented project like eTOX, apart from the predictive quality, the models need to meet other quality parameters related to the procedures for their generation and their intended use. For example, when the models are used for predicting the properties of drug candidates, the prediction system must guarantee the complete confidentiality of the compound structures. The interface of the system must be designed to provide non-expert users all the information required to choose the models and appropriately interpret the results. Moreover, procedures like installation, maintenance, documentation, validation and versioning, which are common in software development, must be also implemented for the models and for the prediction platform in which they are implemented. In this article we describe our experience in the eTOX project and the lessons learned after 7 years of close collaboration between industrial and academic partners. We believe that some of the solutions found and the tools developed could be useful for supporting similar initiatives in the future., The eTOX project (Grant Agreement No. 115002), was developed under the Innovative Medicines Initiative Joint Undertaking (IMI), resources of which are composed of a financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contributions. The authors of this article are also involved in other related IMI projects, such as iPiE (no. 115735), TransQST (no. 116030) and eTRANSAFE (no. 777365), as well as the H2020 EU-ToxRisk project (no. 681002)
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

A Note on the Quarto Chapbooks of the English Don Bellianis

  • Sánchez-Martí, Jordi
  • Sánchez-Martí, Jordi|||/items/fcf90845-a99c-47ac-9403-f5339a2090ae
The sixteenth and seventeenth centuries saw the publication of a large number of Iberian books of chivalry in English translation, including Don Bellianis of Greece, originally written in Spanish in the mid-sixteenth century by Jerónimo Fernández. Don Bellianis was first translated into English in 1598 but had two continuations added in the second half of the seventeenth century that were originally composed in English by Francis Kirkman. While the rest of Iberian chivalric romances stopped being printed in the last decades of the seventeenth century, Don Bellianis was given a new lease of life thanks to its publication in new, shorter formats during the eighteenth century. This note discusses the three chapbook editions printed in London in quarto by William Onley, Charles Brown, and Thomas Norris at the turn of the eighteenth century and sheds new light on their dating and relation to each other. It shows that Brown used Onley’s edition as copy text and printed his edition at the end of 1712, in contrast with the ESTC’s record dating it to between 1682 and 1707. Norris’s edition is based on Brown’s and was printed between 1713 and 1715, rather than in 1715?, as the ESTC indicates. Based on evidence from the Registers of the Stationers’ Company, together with a bibliographical examination of the copies, the new publication dates herein proposed contribute to a better understanding of the place these chapbook editions occupy in the circulation of Don Bellianis in eighteenth-century England.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Charting Amadis de Gaule’s Commercial Success in Early Modern Europe

Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

psygenet2r: a R/Bioconductor package for the analysis of psychiatric disease genes

  • Gutiérrez Sacristán, Alba
  • Hernández Ferrer, Carles
  • González, Juan Ramón
  • Furlong, Laura I.
Motivation: Psychiatric disorders have a great impact on morbidity and mortality. Genotype-phenotype resources for psychiatric diseases are key to enable the translation of research findings to a better care of patients. PsyGeNET is a knowledge resource on psychiatric diseases and their genes, developed by text mining and curated by domain experts. Results: We present psygenet2r, an R package that contains a variety of functions for leveraging PsyGeNET database and facilitating its analysis and interpretation. The package offers different types of queries to the database along with variety of analysis and visualization tools, including the study of the anatomical structures in which the genes are expressed and gaining insight of gene's molecular function. Psygenet2r is especially suited for network medicine analysis of psychiatric disorders. Availability: The package is implemented in R and is available under MIT license from Bioconductor ( http://bioconductor.org/packages/release/bioc/html/psygenet2r.html ). Supplementary information: Supplementary data are available at Bioinformatics online.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

psygenet2r: a R/Bioconductor package for the analysis of psychiatric disease genes

  • Gutiérrez Sacristán, Alba
  • Hernández Ferrer, Carles
  • González, Juan Ramón
  • Furlong, Laura I.
Motivation: Psychiatric disorders have a great impact on morbidity and mortality. Genotype-phenotype resources for psychiatric diseases are key to enable the translation of research findings to a better care of patients. PsyGeNET is a knowledge resource on psychiatric diseases and their genes, developed by text mining and curated by domain experts. Results: We present psygenet2r, an R package that contains a variety of functions for leveraging PsyGeNET database and facilitating its analysis and interpretation. The package offers different types of queries to the database along with variety of analysis and visualization tools, including the study of the anatomical structures in which the genes are expressed and gaining insight of gene's molecular function. Psygenet2r is especially suited for network medicine analysis of psychiatric disorders. Availability: The package is implemented in R and is available under MIT license from Bioconductor ( http://bioconductor.org/packages/release/bioc/html/psygenet2r.html ). Supplementary information: Supplementary data are available at Bioinformatics online.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Development of an infrastructure for the prediction of biological endpoints in industrial environments. Lessons learned at the eTOX Project

  • Pastor Maeso, Manuel
  • Quintana, Jordi
  • Sanz, Ferran
In silico methods are increasingly being used for assessing the chemical safety of substances, as a part of integrated approaches involving in vitro and in vivo experiments. A paradigmatic example of these strategies is the eTOX project http://www.etoxproject.eu, funded by the European Innovative Medicines Initiative (IMI), which aimed at producing high quality predictions of in vivo toxicity of drug candidates and resulted in generating about 200 models for diverse endpoints of toxicological interest. In an industry-oriented project like eTOX, apart from the predictive quality, the models need to meet other quality parameters related to the procedures for their generation and their intended use. For example, when the models are used for predicting the properties of drug candidates, the prediction system must guarantee the complete confidentiality of the compound structures. The interface of the system must be designed to provide non-expert users all the information required to choose the models and appropriately interpret the results. Moreover, procedures like installation, maintenance, documentation, validation and versioning, which are common in software development, must be also implemented for the models and for the prediction platform in which they are implemented. In this article we describe our experience in the eTOX project and the lessons learned after 7 years of close collaboration between industrial and academic partners. We believe that some of the solutions found and the tools developed could be useful for supporting similar initiatives in the future., The eTOX project (Grant Agreement No. 115002), was developed under the Innovative Medicines Initiative Joint Undertaking (IMI), resources of which are composed of a financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contributions. The authors of this article are also involved in other related IMI projects, such as iPiE (no. 115735), TransQST (no. 116030) and eTRANSAFE (no. 777365), as well as the H2020 EU-ToxRisk project (no. 681002)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

DisGeNET-RDF: harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases.

  • Queralt Rosinach, Núria
  • Piñero González, Janet, 1977-
  • Bravo Serrano, Àlex, 1984-
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
MOTIVATION: DisGeNET-RDF makes available knowledge on the genetic basis of human diseases in the Semantic Web. Gene-disease associations (GDAs) and their provenance metadata are published as human-readable and machine-processable web resources. The information on GDAs included in DisGeNET-RDF is interlinked to other biomedical databases to support the development of bioinformatics approaches for translational research through evidence-based exploitation of a rich and fully interconnected linked open data., We received support from ISCIII-FEDER (PI13/00082, CP10/00524), from the IMI-JU under grants agreements no. 115002 (eTOX), no. 115191 (Open PHACTS), no. 115372 (EMIF) and no. 115735 (iPiE), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in kind contribution, and the EU H2020 Programme 2014–2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Uncovering disease mechanisms through network biology in the era of next generation sequencing.

  • Piñero González, Janet, 1977-
  • Berenstein, Ariel José
  • González-Pérez, Abel
  • Chernomoretz, Ariel
  • Furlong, Laura I., 1971-
Characterizing the behavior of disease genes in the context of biological networks has the potential to shed light on disease mechanisms, and to reveal both new candidate disease genes and therapeutic targets. Previous studies addressing the network properties of disease genes have produced contradictory results. Here we have explored the causes of these discrepancies and assessed the relationship between the network roles of disease genes and their tolerance to deleterious germline variants in human populations leveraging on: the abundance of interactome resources, a comprehensive catalog of disease genes and exome variation data. We found that the most salient network features of disease genes are driven by cancer genes and that genes related to different types of diseases play network roles whose centrality is inversely correlated to their tolerance to likely deleterious germline mutations. This proved to be a multiscale signature, including global, mesoscopic and local network centrality features. Cancer driver genes, the most sensitive to deleterious variants, occupy the most central positions, followed by dominant disease genes and then by recessive disease genes, which are tolerant to variants and isolated within their network modules., We received support from UBACyT (20020130100582BA) and MinCyT (PICT2014-2701), ISCIII-FEDER (PI13/00082, CP10/00524), IMI-JU under grants agreements n° 115002 (eTOX), n° 115191 (Open PHACTS)], n° 115372 (EMIF) and n° 115735 (iPiE), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution, and the EU H2020 Programme 2014-2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB). A.G.-P. is supported by a Ramon y Cajal scholarship funded by the Spanish Ministry of Economy. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

psygenet2r: a R/Bioconductor package for the analysis of psychiatric disease genes

  • Gutiérrez Sacristán, Alba
  • Hernández Ferrer, Carles
  • González, Juan Ramón
  • Furlong, Laura I., 1971-
MOTIVATION: Psychiatric disorders have a great impact on morbidity and mortality. Genotype-phenotype resources for psychiatric diseases are key to enable the translation of research findings to a better care of patients. PsyGeNET is a knowledge resource on psychiatric diseases and their genes, developed by text mining and curated by domain experts. RESULTS: We present psygenet2r, an R package that contains a variety of functions for leveraging PsyGeNET database and facilitating its analysis and interpretation. The package offers different types of queries to the database along with variety of analysis and visualization tools, including the study of the anatomical structures in which the genes are expressed and gaining insight of gene's molecular function. Psygenet2r is especially suited for network medicine analysis of psychiatric disorders. AVAILABILITY AND IMPLEMENTATION: The package is implemented in R and is available under MIT license from Bioconductor (http://bioconductor.org/packages/release/bioc/html/psygenet2r.html)., This work was supported by ISCIII-FEDER [PI13/00082, CP10/00524, CPII16/00026], MICINN [MTM2015-68140-R], IMI-JU under grants agreements no. 115191 (Open PHACTS), no. 115372 (EMIF), no. 115735 (iPiE), resources of which are composed of financial contribution from the EU-FP7 [FP7/2007–2013] and EFPIA companies in kind contribution, and the EU H2020 Programme 2014–2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a member of ELIXIR-ES and the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023, of the PE I + D+i 2013-2016, funded by ISCIII and FEDER. A.G.S. acknowledges financial support from the Spanish Ministry of Economy and Competitiveness, through the ‘María de Maeztu’ Programme for Units of Excellence in R&D [MDM-2014-0370].
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Entre las caballerías y la picaresca, la obra en prosa de Francis Kirkman (1632-c.1680), Between Romances of Chivalry and the Picaresque

  • Sumillera, Rocio G.|||0000-0002-9497-8688
Este artículo explora la convergencia de los géneros de la novela de caballerías y la picaresca a través del análisis de la obra en prosa del escritor y librero londinense Francis Kirkman (1632-c.1680), traductor al inglés del libro sexto del ciclo de Amadís, continuador de Belianís de Grecia y de The English Rogue, autor de la biografía de la impostora Mary Carleton, The Counterfeit Lady Unveiled, y de la suya propia, The Unlucky Citizen. Tomando la obra en prosa de Kirkman a modo de estudio de caso, particularmente su narrativa autobiográfica, se estudia cómo los géneros de las novelas de caballerías y la picaresca terminan entremezclándose en la literatura inglesa del siglo XVII., This article explores the intersection of romances of chivalry and the picaresque through theanalysis of a selection of works in prose by the London writer and bookseller Francis Kirkman(1632-c.1680), translator into English of Book VI of the Amadis cycle, continuator of Bellianis of Greece (Parts II-III) and of The English Rogue (Parts II-IV), and author of, among others, the biography of the impostor Mary Carleton, The Counterfeit Lady Unveiled, and of his own, The Unlucky Citizen. Taking Kirkman's prose works as a case study, with a particularfocus on his autobiographical narrative, it will be seen how both genres, i.e. romances of chivalry and the picaresque, end up intertwining in seventeenth-century English literature.